EUVIMEDEUVIMED entdecken
Crossref

Hypocalcemia and cardiovascular mortality in cinacalcet users

Shunsuke Goto iD, Takayuki Hamano, Hideki Fujii iD, Masatomo Taniguchi, Masanori Abe, Kosaku Nitta, Shinichi Nishi

Nephrology Dialysis Transplantation · 27.03.2024 · 39 (4) · 637-647

DOI: 10.1093/ndt/gfad213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, erschienen am 27.03.2024. Verfasst von Shunsuke Goto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan. Hauptthemen laut MEDLINE: Hypocalcemia, Hyperparathyroidism, Secondary, Heart Failure. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Calcimimetics are widely used in hemodialysis patients and influence serum calcium levels. Although the Kidney Disease: Improving Global Outcomes guidelines argued that low calcium levels induced by calcimimetics may be harmless, large observational studies investigating the association between hypocalcemia and mortality are scarce. We investigated the association between serum calcium levels and cardiovascular mortality in calcimimetics users using the nationwide Japanese registry for dialysis patients.

Methods

In this 9-year prospective cohort study, the baseline data were collected at the end of 2009. We enrolled patients on maintenance hemodialysis or hemodiafiltration. We employed three models (baseline, time-dependent and time-averaged) to conduct Cox proportional hazard regression analyses.

Results

Cinacalcet was prescribed to 12.7% (N = 22 853) at baseline. The median observation period was 98 (interquartile range 40–108) months and 108 (interquartile range 59–108) months in the whole cohort (N = 180 136) and in cinacalcet users, respectively. Three-quarters of survivors at the end of 2019 had continued calcimimetic therapy for 10 years, corresponding to a mean annual dropout rate of 2.9%. Hypocalcemia was not associated with cardiovascular mortality in the baseline or time-averaged model. In the time-dependent model, however, the lowest calcium decile (corrected calcium <8.4 mg/dL) was significantly associated with higher cardiovascular mortality than the reference (corrected calcium 8.7–8.9 mg/dL) in both cinacalcet users and all patients [hazard ratio (95% confidence interval) 1.32 (1.00, 1.75) and 1.15 (1.05, 1.26), respectively]. Hypocalcemia was especially associated with sudden death and death due to hemorrhagic stroke, heart failure and ischemic heart disease. Higher rate of fatal and non-fatal cardiovascular events was observed in hypocalcemic patients regardless of cinacalcet usage.

Conclusions

Our findings suggest that transient hypocalcemia was associated with an increased risk of cardiovascular death independent of cinacalcet usage. We should pay attention to hypocalcemia transiently induced by cinacalcet.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypocalcemiaHyperparathyroidism, SecondaryHeart FailureHumansCinacalcetCalciumProspective StudiesRenal DialysisParathyroid HormoneCalcimimetic Agents

Stichwörter der Autor:innen

PTHcalcimimeticscalciumcardiovascularhemodialysis

Substanzen

CinacalcetCalciumParathyroid HormoneCalcimimetic Agents

Autor:innen und Institutionen

  • Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
  • Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Nephrology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Fukuoka Renal Clinic, Fukuoka, Japan.
  • Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.

ORCID-Profile: Shunsuke Goto, Hideki Fujii

Zitieren

APA

Goto, S., Hamano, T., Fujii, H., Taniguchi, M., Abe, M., Nitta, K., & Nishi, S. (2024). Hypocalcemia and cardiovascular mortality in cinacalcet users. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad213

Vancouver

Goto S, Hamano T, Fujii H, Taniguchi M, Abe M, Nitta K, et al. Hypocalcemia and cardiovascular mortality in cinacalcet users. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad213

BibTeX
@article{Goto2024,
  author = {Goto, Shunsuke and Hamano, Takayuki and Fujii, Hideki and Taniguchi, Masatomo and Abe, Masanori and Nitta, Kosaku and Nishi, Shinichi},
  title = {Hypocalcemia and cardiovascular mortality in cinacalcet users},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfad213}
}
Kostenlos starten →